Chidamide in Combination With Toripalimab and Anlotinib in Recurrent/Metastatic Nasopharyngeal Carcinoma.
Clinical trial NCT07320963 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07320963
- Sponsor
- Sun Yat-sen University
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-03-31
- Primary completion
- 2027-03-28
- Enrollment
- 52
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.